Literature DB >> 3552221

Indicine N-oxide: clinical use of a pyrrolizidine alkaloid.

S A King, M Suffness, B Leyland-Jones, D F Hoth, P J O'Dwyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3552221

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

1.  Phase I trial of indicine-N-oxide in children with leukemia and solid tumors: a Pediatric Oncology Group study.

Authors:  V M Whitehead; M L Bernstein; R Vega; T Vats; P Dyment; T J Vietti; J Krischer
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 2.  Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive agent.

Authors:  L H Patterson
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.